# EDGAR Filing Document

**Accession Number:** 0000883241
**File Stem:** 0001199719-25-000011
**Filing Date:** 2025-7
**Character Count:** 12060
**Document Hash:** c1a16c7007814897ac729fe9bb2430cb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001199719-25-000011.hdr.sgml**: 20250724

**ACCESSION NUMBER**: 0001199719-25-000011

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250717

**FILED AS OF DATE**: 20250724

**DATE AS OF CHANGE**: 20250724

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** LEE JANET
- **CENTRAL INDEX KEY:** 0001711671

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-19807
- **FILM NUMBER:** 251148167

**MAIL ADDRESS:**
- **STREET 1:** 2600 ANSYS DRIVE
- **CITY:** CANONSBURG
- **STATE:** PA
- **ZIP:** 15317
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SYNOPSYS INC
- **CENTRAL INDEX KEY:** 0000883241
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 561546236
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**BUSINESS ADDRESS:**
- **STREET 1:** 675 ALMANOR AVE
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94085
- **BUSINESS PHONE:** 6505845000

**MAIL ADDRESS:**
- **STREET 1:** 675 ALMANOR AVE
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94085

## Ex-24

```

SYNOPSYS, INC.
POWER OF ATTORNEY

The undersigned hereby constitutes and appoints each of John F. Runkel, Jr.,
Erika Varga McEnroe, Derek Chien, Dipika Lakhmani, Mary Lai, Liz Ramirez,
and Anna Felix; each acting individually, as his/her true and lawful
attorney-in-fact to:

(1)	prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission
(the "SEC") a Form ID, including amendments thereto, and any other
documents necessary or appropriate to obtain codes and passwords
enabling the undersigned to make electronic filings with the SEC of
reports required by Section 16(a) of the Securities Exchange Act of 1934,
as amended, and the rules and regulations promulgated thereunder
(the "Exchange Act"), or any rule or regulation of the SEC;

(2)	execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer or director of Synopsys, Inc. (the "Company"), any
and all Initial Statements of Beneficial Ownership of Securities on Form 3,
Statements of Change of Beneficial Ownership of Securities on Form 4 and
Annual Statements of Beneficial Ownership of Securities on Form 5 (including
amendments thereto) in accordance with Section 16(a) of the Exchange Act;

(3)	execute for and on behalf of the undersigned Form 144 (including
amendments thereto), in accordance with Rule 144 under the Securities Act
of 1933, as amended, and the rules and regulations promulgated thereunder
(the "Securities Act");

(4)	execute for and on behalf of the undersigned Schedule 13D or
Schedule 13G (including amendments thereto) in accordance with Sections 13(d)
and 13(g) of the Exchange Act, and Form 13F or Form 13H
(including amendments thereto) in accordance with Sections 13(f) and
13(h) of the Exchange Act;

(5)	do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such form, schedule or other documentation pursuant
to the Securities Act and/or Exchange Act, including, but not limited to,
Form ID, Form 3, Form 4, Form 5, Form 144, Schedule 13D,
Schedule 13G, Form 13F or Form 13H (including any amendments thereto)
(such Forms and Schedules, "Required Documentation")
and timely file such report with the SEC and any stock exchange,
stock market or similar authority; and

(6)	take any other action of any type whatsoever in connection with
the foregoing that, in the opinion of such attorney-in-fact, may be
of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned, pursuant to this
Power of Attorney, shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in his/her
discretion.

The undersigned hereby grants to such attorney-in-fact full power
and authority to do and perform all and every act and thing whatsoever
requisite, necessary, and proper to be done in the
exercise of any of the rights and powers herein granted, as fully to
all intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact,
or his/her substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers
herein granted. The undersigned acknowledges that no such
attorney-in-fact, in serving in such capacity at the
request of the undersigned, is hereby assuming, nor is the Company hereby
assuming, any of the undersigned's responsibilities
to comply with Section 16, Sections 13(d) and 13(g) or Sections 13(f)
and 13(h) of the Exchange Act or Rule 144 under the Securities Act.

This Power of Attorney shall supersede and revoke any Power of Attorney
previously executed with respect to any Required Documentation and shall
remain in full force and effect until the undersigned is no longer required
to file such Required Documentation, unless earlier revoked by the undersigned
in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of June 2, 2025.

	/s/ Janet Lee
	Janet Lee

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>LEE JANET<br><sub>(Last) (First) (Middle)</sub><br>675 ALMANOR AVENUE<br><sub>(Street)</sub><br>SUNNYVALE, CA 94085<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>SYNOPSYS INC [ SNPS ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-07-17 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_GC & Corporate Secretary_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 8298<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units<sup>(2)</sup> | 2025-12-31<sup>(3)</sup> | 2025-12-31 | Common Stock | 5385<sup>(4)</sup> | $0.0 | D |  |
| Restricted Stock Units<sup>(2)</sup> | 2025-09-03<sup>(5)</sup> | 2026-03-03 | Common Stock | 878 | $0.0 | D |  |
| Restricted Stock Units<sup>(2)</sup> | 2025-09-01<sup>(6)</sup> | 2027-03-01 | Common Stock | 4894 | $0.0 | D |  |
| Restricted Stock Units<sup>(2)</sup> | 2026-02-16<sup>(7)</sup> | 2028-02-16 | Common Stock | 8705 | $0.0 | D |  |

---

### Footnotes:

(1) On July 17, 2025, Synopsys, Inc. (Synopsys) completed its merger with ANSYS, Inc. (Ansys), pursuant to the Agreement and Plan of Merger, dated January 15, 2024 (Merger Agreement), by and among Synopsys, Ansys and ALTA Acquisition Corp., a wholly owned subsidiary of Synopsys (Merger Sub). Pursuant to the Merger Agreement, Merger Sub was merged with and into Ansys (Merger), with Ansys surviving the Merger as a wholly owned subsidiary of Synopsys. At the effective time of the Merger (Effective Time), each share of common stock, par value $0.01 per share, of Ansys (Ansys Common Stock) issued and outstanding immediately prior to the Effective Time (subject to certain exceptions) was converted into the right to receive (i) 0.3399 of a share of common stock, par value $0.01 per share, of Synopsys (Synopsys Common Stock) (rounded down to the nearest whole share) and (ii) $199.91 in cash (plus cash in lieu of any fractional share of Synopsys Common Stock), without interest.

(2) Pursuant to the terms of the Merger Agreement, at the Effective Time, certain Ansys restricted stock units (RSUs) were converted into a number of Synopsys RSUs (rounded to the nearest whole share) equal to the product of (i) the number of shares of Ansys Common Stock subject to such Ansys RSU, including any accrued but unpaid dividend equivalents thereon, multiplied by (ii) 0.6952. Except as set forth in Footnote 4 with respect to Ansys PSUs, the Synopsys RSUs described herein will remain subject to the same terms and conditions as were applicable to the underlying Ansys RSU immediately prior to the Effective Time.

(3) Subject to the continued service of the Reporting Person through the vesting date, the RSUs will vest on December 31, 2025.

(4) Reflects Synopsys RSUs that were issued following the conversion of Ansys RSUs that prior to the Effective Time were subject to vesting on the basis of time and the achievement of performance targets (Ansys PSUs). Pursuant to the terms of the Merger Agreement, for purposes of the conversion described in Footnote 2, the number of shares of Ansys Common Stock subject to such Ansys PSU award was based on the attainment of applicable performance metrics at the (x) actual level of performance for performance periods that lapsed in the ordinary course prior to the Effective Time or (y) for each other Ansys PSU, the target level of performance.

(5) Subject to the continued service of the Reporting Person through each vesting date, the RSUs will continue to vest in approximately equal quarterly installments on the third of every September, December and March until March 3, 2026.

(6) Subject to the continued service of the Reporting Person through each vesting date, the RSUs will continue to vest in approximately equal quarterly installments on the first of every September, December, March and June until March 1, 2027.

(7) Subject to the continued service of the Reporting Person through each vesting date, approximately one-third of the RSUs will vest on February 16, 2026, followed by vesting in approximately equal quarterly installments on the sixteenth of every August, November, February and May until February 16, 2028.

**Signature:** By: POA pursuant Liz Ramirez For: Janet Lee  
**Date:** 2025-07-24

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**